Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 24INDUSTRY 2OTHER_GOV 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 4Thoracic 1Sarcoma 1Lymphoid 1Head & Neck 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Colorectal Neoplasms 115Rectal Neoplasms 77Colonic Neoplasms 71Pancreatic Neoplasms 38Stomach Neoplasms 34Esophageal Neoplasms 29Anus Neoplasms 18Adenocarcinoma Of Esophagus 17Carcinoma, Non-Small-Cell Lung 14Carcinoma, Hepatocellular 14Breast Neoplasms 14Biliary Tract Neoplasms 14Neoplasm Metastasis 11Liver Neoplasms 11Lung Neoplasms 10Sarcoma 9Hepatoblastoma 9Gastrointestinal Stromal Tumors 9Ovarian Neoplasms 8Neoplasms 8HIV Infections 8Prostatic Neoplasms 7Gallbladder Neoplasms 7Esophageal Squamous Cell Carcinoma 7Anal Canal Carcinoma 7Small Cell Lung Carcinoma 6Precancerous Conditions 6Neuroblastoma 6Uterine Cervical Neoplasms 5Osteosarcoma 5

Interventions

Ondansetron 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Vomiting × Gastrointestinal × Clear all
NCT00016380 2020-04-03

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Canadian Cancer Trials Group

Phase 3 Completed
211 enrolled
GastrointestinalGynecologic

Carcinoma, Ovarian Epithelial, Appendiceal Neoplasms, Bile Duct Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Nausea, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Vomiting, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡